OIS XIV Speakers

Physician scientist (UK trained ophthalmologist) with over 20 years drug discovery and development experience. Current role is Head of Translational Medicine at Apellis. Broad responsibilities…

Dr. Tomo Oe currently holds the role of Scouting & Transaction Lead in Business Development at Astellas Pharma, where he leads search & evaluation and…

Joe is joining from Boston Consulting Group, where he worked with healthcare and private equity clients on strategy, portfolio planning, and due diligence projects. Prior…

Amy Hopkin is an accomplished leader in the pharmaceutical and medical device industries with over a decade of experience in driving innovation and strategic growth.…

Ms. Susan Benton is a strategic business consultant and owner of i2eye Consulting, LLC. Since July 2024, she has been a strategic advisor and consultant…

Dr. Gebauer has more than 30 years industry experience in research and development and has been part of teams responsible for numerous approvals worldwide in…

Kirstie Cole brings 25 years of strategic sales and leadership experience to Bausch + Lomb. Known for driving consistent growth and building high-performing teams, Kirstie…

Dr. Friedman oversees a family office that focuses on private companies in the biotechnology and pharmaceutical space, with an emphasis on platform technologies, oncology, neurodegenerative…

Dr. Myung is an Associate Professor of Ophthalmology at the Byers Eye Institute at Stanford and, by courtesy, of Chemical Engineering. He is a board-certified…

Natalie Afshari, MD, FACS, is Chief of Cornea and Refractive Surgery and is accomplished as a clinician, surgeon, and research scientist. She received her medical…

Dr. Michael Abramoff, MD, PhD, (FARVO) is the Robert C. Watzke, MD Professor of Ophthalmology and Visual Sciences at the University of Iowa, with a…